Tag Archives: Roche Holding AG

Glaxo, Google Parent Create $715 Million Bioelectronic Medicines Venture

GlaxoSmithKline PLC (London) and Google parent Alphabet Inc. (Mountain View CA) have teamed up to develop what they call bioelectronic medicines, or treatments that use miniature implanted electronic devices to modify how electrical impulses are… Read more »

Wall Street Ponders Brexit’s Impact on Drug, Biotech Stocks

In a historic vote Thursday, Britain has decided to leave the European Union. And, swallowing hard, financial markets around the world are not taking the news very well. Stateside, the Dow… Read more »

First False Claims Act Settlement Turns on Cancer-Drug Survival Data

In the first False Claims Act settlement that turns on cancer-drug survival data, Roche Holding AG’s (Basel CHE) Genentech unit and OSI Pharmaceuticals LLC (Farmingdale NY) agreed to pay $67… Read more »

Drugs Targeting DNA Repair Mechanisms Inside Cells Show Promise in Fight Against Cancer

Drugs targeting DNA repair mechanisms inside cells are showing significant promise for a range of tumors and AstraZeneca PLC (London) believes it is well ahead of rivals in the emerging… Read more »

AstraZeneca Joins with Three Partners to Focus on Genomics

AstraZeneca PLC (London), working with genome pioneer J. Craig Venter, PhD, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential… Read more »